Related Experiment Video
Updated: Aug 9, 2025

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
Jingbing Lou1,2, Hongliang Zhang1,2, Qingshan Huang1,2
1Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, People's Republic of China.
Abstract:
CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progression. Moreover, we observed that circTLK1 showed high expression in chordoma cells and tissues, while circTLK1 interference suppressed chordoma cell proliferation and invasion. In addition, circTLK1 directly interacted with miR-16-5p, which has previously been shown to repress chordoma, and circTLK1 knockdown suppressed Smad3 expression. Chromatin immunoprecipitation sequencing further demonstrated that Smad3 acts as a positive regulator by interacting with TLK1, thereby mediating the circTLK1/miR-16-5p/Smad3 positive feedback axis. Taken together, our findings suggested that the disruption of the circTLK1/miR-16-5p/Smad3 positive feedback pathway, particularly via the Smad3 inhibitor SIS3, could be a promising therapeutic strategy.
Insights
Circular RNAs (circRNAs) like circTLK1 regulate cancer. This study found circTLK1 promotes chordoma progression by forming a feedback loop with miR-16-5p and Smad3, suggesting therapeutic targeting.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Circular RNAs (circRNAs) are key regulators in various cancers.
- The specific roles of circRNAs in chordoma progression are not fully understood.
- MicroRNAs (miRNAs) are known to regulate tumor suppressor pathways.
Purpose of the Study:
- To investigate the role of circTLK1 in chordoma.
- To elucidate the regulatory mechanism of circTLK1 in chordoma progression.
- To identify potential therapeutic targets for chordoma.
Main Methods:
- Bioinformatic analyses to identify circTLK1.
- Cell culture and tissue analysis to assess circTLK1 expression and function.
- RNA immunoprecipitation and chromatin immunoprecipitation sequencing to determine molecular interactions.
- In vitro assays to evaluate cell proliferation and invasion.
- Pharmacological inhibition using SIS3.
Main Results:
- CircTLK1 expression is significantly upregulated in chordoma tissues and cells.
- CircTLK1 knockdown inhibits chordoma cell proliferation and invasion.
- CircTLK1 directly binds to miR-16-5p, sequestering its tumor-suppressive activity.
- CircTLK1 knockdown leads to decreased Smad3 expression.
- Smad3 positively regulates TLK1 expression, establishing a circTLK1/miR-16-5p/Smad3 positive feedback loop.
- The Smad3 inhibitor SIS3 disrupts this feedback loop.
Conclusions:
- CircTLK1 acts as an oncogene in chordoma by regulating the circTLK1/miR-16-5p/Smad3 feedback axis.
- Targeting this feedback loop, potentially with Smad3 inhibitors like SIS3, represents a promising therapeutic strategy for chordoma.
More Related Videos
08:33Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
Published on: April 25, 2014
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...